Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00315263 · ClinicalTrials.gov registry record
Genomics, Single Nucleotide Polymorphisms (SNPs), and Clinical Neonatology
A clinical trial, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- 63
- Enrollment target
NCT00315263 is a clinical trial that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 63 participants.
The verdict
NCT00315263 has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- 63 participants
- Enrollment target
Study Summary
This research seeks to establish a neonatal DNA Tissue Bank to find out if differences in small segments of DNA predispose babies to Chronic Lung Disease (CLD), Periventricular Brain Injury (PVI), Necrotizing Enterocolitis (NEC), or Hypoxic Respiratory Failure (HRF).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2006-04 |
| Est. Completion | 2011-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00315263
The ClinicalTrials.gov registry entry for NCT00315263 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00315263 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00315263 about?
NCT00315263 is a clinical study titled "Genomics, Single Nucleotide Polymorphisms (SNPs), and Clinical Neonatology". This research seeks to establish a neonatal DNA Tissue Bank to find out if differences in small segments of DNA predispose babies to Chronic Lung Disease (CLD), Periventricular Brain Injury (PVI), Necrotizing Enterocolitis (NEC), or Hypoxic Respiratory Failure (HRF).
What is the current status of trial NCT00315263?
This trial is currently completed. The enrollment target is 63 participants. The study started on 2006-04. Estimated completion is 2011-07.
Who is sponsoring clinical trial NCT00315263?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.